Litocid
Litocid
tablets
Composition:
Potassium citrate
Form and dose:
Modified release tablets, 680 mg
Package:
100 tablets
Indications:
Calcium nephrolithiasis in patients with low urinary citrate excretion. Renal distal tubular acidosis, metabolic acidosis in chronic renal failure with no significant reduction in daily urine volume and without hyperkalemia. Supplementing potassium deficiency in the body. Other pathological conditions requiring chronic urine alkalinization.
Availability:
Prescription drug
Marketing authorization number:
9317
For doctors
downloads
For wholesalers
Sales department
tel.: +48 71 326 14 91
fax: +48 71 326 14 57
e-mail: handlowy@labor.com.pl
For patients
downloads
Visit us
49 Długosza str.
51-162 Wrocław, Poland
Reporting of Adverse Drug Reaction for the patient
Reporting side effects for the heathcare professional
Call us
+ 48 71 325 30 85/86